In accordance requirement of regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A (1) of Part A of Schedule III and SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015, Eris Lifesciences has informed that it attached details and the same will be uploaded on the website of the Company.
The above information is a part of company’s filings submitted to BSE.